Familial breast cancer: Part IV: Survival of familial breast cancer in Bulgarian patients

Journal of B.U.ON.

Volumn 8, Issue 4, 2003, Pages 351-356

  Gavrilov, Ivan ^a   Nacheva, M ^b   Tzingilev, D ^a  

^a National Oncology Center Bulgaria   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Familial predisposition; Hereditary breast cancer; Prognostic factors; Survival

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ARTICLE; BREAST CANCER; BULGARIA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILIAL CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURVIVAL RATE;

EID: 2442684231     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Albano W, Recabaren J, Lynch H et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982; 50: 360-363.
2. Lynch H, Albano W, Recabaren J at al. Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 1981; 7: 1201-1209.
3. Malone K, Daling J, Weiss N et al. Family history and survival of young women with invasive breast cancer. Cancer 1996; 78: 1417-1425.
4. Slatery M, Berry T, Kerber R. Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology 1993; 4: 543-548.
5. Less AW, Jenkins HJ, May CL et al. Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 1989; 13: 143-151.
6. Anderson D, Badzioch M. Survival in familial breast cancer patients. Cancer 1986; 58: 360-365.
7. Wobbes T, van de Wiel M, van der Sluis R et al. The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol 1987; 13: 119-121.
8. Ruder A, Moodie P, Nelson N et al. Does family history of breast cancer improve survival among patients with breast cancer? Am J Obstet Gynecol 1988; 158: 963-968.
9. Ansquer Y, Gautier C, Fourquet A et al. Survival in early-onset BRCA1 breast cancer patients. Lancet 1998; 352: 541 (letter).
10. Anderson DE. Breast cancer in families. Cancer 1977; 40: 1855-1860.
11. Skolnic M, Cunnon-Albright L. Genetic predisposition to breast cancer. Cancer 1992; 70: 1747-1754.
12. Lakhani SR, Jacquemier J, Sloane JP et al. Multifactorial analysis of differences between sporadic breast cancer and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998; 90: 1138-1145.
13. Johannsson O, Ranstam J, Borg A et al. Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden. J Clin Oncol 1998; 16: 397-404.
14. Otter W, Koten JW, Vegt BJ et al. Hereditary cancer and its clinical implications: a view. Anticancer Res 1990; 10: 489-496.
15. Gavrilov I, Nacheva M, Tzingilev D. Familial breast cancer. Part I: clinical studies; combined effect of family history, age and reproductive factors on breast cancer development. J BUON 2001; 6: 189-193.
16. Gavrilov I, Nacheva M, Tzingilev D. Familial breast cancer. In: Timcheva K, Todorov D, Moretti JL (eds). Studia Oncologia. Focus Publ, Jakoruda, Blagoevgrad 2000, pp 81-130 (in Bulgarian).
17. Gavrilov I, Nacheva M, Tzingilev D. Familial breast cancer. Part II: Relationship with histology, staging, steroid receptors and serum tumor markers. J BUON 2002; 7: 61-65.
18. Nacheva M, Gavrilov I, Tzingilev D. Familial breast cancer. Part III:Genome instability and cancer risk. J BUON 2002; 7: 149-152.
19. Tenev V, Krasteva E, Gavrilov I, Pandova V. Familial breast cancer. In: Chernozemski I (ed). Systematical recommendations for diagnosis, treatment and follow-up of patients with neoplastic diseases. Academic Marin Drinov Publ, Bulgarian Academy of Sciences, Sofia, 2000 (in press).
20. Wobbes T, van de Wiel M, van der Sluis R et al. The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol 1987; 13:119-121.
21. Ruder A, Moodie P, Nelson N et al. Does family history of breast cancer improve survival among patients with breast cancer? Am J Obstet Gynecol 1988; 158:963-968.
22. Marcus J, Watson P, Paje D et al. Hereditary breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 link-age. Cancer 1996; 77:687-709.
23. Porter D, Cohen B,Wallace M et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994; 81:1512-1515.
24. Anderson DE. Some characteristics of familial breast cancer. Cancer 1971; 28: 1500-1504.
25. Somerfield MR. Clinical practice guidelines for the use of tumor markers in breast cancer and colorectal cancer. J Clin Oncol 1996; 14: 2843-2877.
26. Graham AC, Bernard AR, Frank ES. Risk factor for breast cancer according to family history of breast cancer. J Natl Cancer Inst 1996; 88: 365-371.
27. Eisinger F, Albi N, Bremond A et al. Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee. Ann Oncol 1998; 9: 939-950.
28. de Cremoux P, Salomon AV, Dendale SLR et al. p53 mutation as a genetic trait of typical medullary breast carcinoma. J Natl Cancer Inst 1999; 91: 641-643.
29. Habel LA, Stanford JL. Hormone receptors and breast cancer. Epidemiol Rev 1993; 15:209-219.
30. Mansour EG, Ravdin PM, Dressler LI. Prognostic factors in early breast carcinoma. Cancer 1994; 74: 381-400.
31. Hulka BS, Lin ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer 1994; 74: 1111-1124.